Combination will create a Canadian Health Champion spanning generic, biosimilar and branded pharmaceuticals
Liraglutide is a drug-device combination formulation used in the treatment of Type 2 Diabetes Mellitus
Ukrainian marketing approvals for paclitaxel, oxaliplatin and irinotecan mark a significant milestone in the company’s global expansion strategy
The disbursement will bolster the company's manufactun'ng capabjljties and foster product diversification, including complex generics
The WHO GMP approved vertically integrated ONCOLOGY unit of SAKAR has been selling products nationally since few quarters
Sadhana Nitro Chem's plant is the second plant in the world to manufacture pAP from Nitrobenzene
Cipla completes transfer of Generics Business Undertaking
Subscribe To Our Newsletter & Stay Updated